Diabetes and metabolic syndrome as risk factors for COVID-19
- 8 May 2020
- journal article
- research article
- Published by Elsevier BV in Diabetes & Metabolic Syndrome: Clinical Research & Reviews
- Vol. 14 (4), 671-677
- https://doi.org/10.1016/j.dsx.2020.05.013
Abstract
No abstract availableKeywords
Funding Information
- Javna Agencija za Raziskovalno Dejavnost RS (P1-0055)
This publication has 53 references indexed in Scilit:
- Charting the NF-κB Pathway Interactome MapPLOS ONE, 2012
- ACE2 and Diabetes: ACE of ACEs?Diabetes, 2010
- Metabolic syndrome is linked to a mild elevation in liver aminotransferases in diabetic patients with undetectable non-alcoholic fatty liver disease by ultrasoundDiabetology & Metabolic Syndrome, 2010
- Angiotensin I–Converting Enzyme Type 2 (ACE2) Gene Therapy Improves Glycemic Control in Diabetic MiceDiabetes, 2010
- The sweeter side of ACE2: Physiological evidence for a role in diabetesMolecular and Cellular Endocrinology, 2009
- Network properties of genes harboring inherited disease mutationsProceedings of the National Academy of Sciences of the United States of America, 2008
- The human disease networkProceedings of the National Academy of Sciences of the United States of America, 2007
- ACE2: from vasopeptidase to SARS virus receptorTrends in Pharmacological Sciences, 2004
- Characterization of Renal Angiotensin-Converting Enzyme 2 in Diabetic NephropathyHypertension, 2003
- A Human Homolog of Angiotensin-converting EnzymeJournal of Biological Chemistry, 2000